Amazing progress being made with the?$3.7 million CEPI (Coalition for Epidemic Preparedness Innovations) grant?to advance Micron Biomedical’s?groundbreaking needle-free vaccine delivery technology. This innovative system uses dissolvable microneedles activated by a button to painlessly administer vaccines, making it a potential game-changer for global health, particularly in hard-to-reach areas. CastleVax is proud to be contributing to this important research by exploring the combination of this technology with our?rapid-response vaccine platform. Together, we’re working towards a more efficient and equitable way to tackle future viral outbreaks. We’re excited to be part of this forward-thinking collaboration and look forward to the potential it holds for transforming vaccine access worldwide. Read more here: https://lnkd.in/gN3BVcyf #vaccinedevelopment #castlevax #vaccineaccess #biotech #nextgen
CEPI (Coalition for Epidemic Preparedness Innovations) is awarding Micron Biomedical $3.7 million in new funding to study Micron’s needle-free microarray technology in combination with a next-generation vaccine platform technology developed by?CastleVax?that can be quickly adapted to protect against different pathogens in response to novel viral threats. This is the first time that Micron’s technology will be studied with a rapid-response vaccine platform.? ? We are grateful for CEPI’s generous award, and its recognition of Micron’s unique potential to more efficiently and effectively respond to future disease outbreaks.??Read the full announcement here: https://lnkd.in/gN3BVcyf